Regenerative and alternative therapies—such as peptides, NAD+, ketamine, and stem cells—are rapidly expanding across healthcare and medspa settings. While these treatments present new opportunities for providers, they also introduce complex Healthcare Liability exposures.
Now available on demand, this webinar features experts from Burns & Wilcox and GenStar Insurance Services as they explore evolving standards of care, regulatory scrutiny, and coverage challenges tied to off-label and investigational treatments.
Watch the recording to gain insight into how to identify coverage gaps, navigate underwriting considerations, and position clients effectively.
Featured experts:
- Lily Chetosky, Broker, Professional Liability, Burns & Wilcox, Chicago, Illinois
- Kelli Bernstein, Inside Broker, Burns & Wilcox, Brokerage Division, Atlanta, Georgia
- Carrie Roberts, RPLU, Vice President, Professional Brokerage Division, GenStar Insurance Services
Hosted by Laura McCormick, Vice President, Regional Practice Group Leader, Professional, Dallas/Ft. Worth, Texas
